Aloe vera leaf
Identification
- Brand Names
- Alcortin A, Aloquin
- Generic Name
- Aloe vera leaf
- DrugBank Accession Number
- DB13906
- Background
Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern peninsula and various islands. Aloe vera, or Aloe barbadensis miller, is the most common species of Aloe that is cultivated for agricultural and medical purposes. It is a perennial succulent xerophyte with elongated leaves that contain a clear gel. While aloe vera has a long history of commercial uses, it is still widely used in cosmetic, food and pharmaceutical products. The use of aloe vera in constipation, inflammatory disorders, cancer, ulcer, and diabetes has also been investigated 4. The active constituents of aloe vera include polysaccharides with protective effects on skin, as they exhibit antioxidant and anti-inflammatory properties 5. Common active polysaccharides include glucomannans, polymannose, and acemannan, or b-(1–4)-acetylated polymannose 3. Acemannan and other modified polysaccharides are responsible in preventing suppression of contact hypersensitivity or immune suppression induced by external factors such as irradiation 2.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Aloe
- Aloe (aloe barbadensis)
- Aloe barbadensis leaf
- Aloe barbadensis leaf extract
- Aloe barbadensis leaf juice
- Aloe barbadensis leaf juice powder
- Aloe barbadensis leaf powder
- Aloe barbadensis leaf water
- Aloe folii extractus (aloe vera)
- Aloe folium (aloe vera)
- Aloe herba (aloe vera)
- Aloe leaf extract
- Aloe vera
- Aloe vera dry leaf juice
- Aloe vera extract
- Aloe vera leaf extract
- Aloe vera leaf exudate
- Aloe vera leaf juice
- Aloe vera leaf mucilage
- Aloe vera leaf powder
- Aloe vera mucilage
- Aloes
- Aloes (aloe barbadensis)
- Barbatos aloe leaf
- Curacao aloe leaf
- Ghrita kumari leaf
- Kanyasara
- Lu hui (aloe vera)
- Lu hui ye
- Luhui (aloe barbadensis)
- External IDs
- Fema no. 2047
Pharmacology
- Indication
Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first- and second-degree burns, radiation dermatitis, and sunburn.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Acne ••• ••••• Treatment of Atopic dermatitis ••• ••••• Treatment of Contact dermatitis and other eczema ••• ••••• Treatment of Dermatosis ••• ••••• Treatment of Eczema ••• ••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Aloe polysaccharides mediate antioxidant and anti-inflammatory actions, as well as immunoregulatory activities. Various studies indicate that aloe polysaccharides possess effective free radical scavenging activity in vitro, and produce potent antioxidant potential during oxidative stress in vivo 4. According to the findings of studies in vitro and in vivo, aloe polysaccharides exhibit radioprotective activity. Treatment with acemmanan, which is a common aloe polysaccharide, on CH3 mice with radiation-induced skin reactions resulted in reduced signs of those reactions 2. Studies suggest that aloe polysaccharides may evidently attenuate tumor growth in mice 2. Treatment of aloe polysaccharides in Vero cells as well as in the in vivo zebrafish model led to protective effects against AAPH-indued oxidative stress resulting from accumulation of free radical species and improved cell viability 1.
- Mechanism of action
It is suggested that aloe polysaccharides mediate skin-protectant effects in damaged skin, induced by internal or other external factors such as radiation, via inhibiting apoptosis of normal cell lines in vitro and thrombocytes in vivo 2. Following irradiation, aloe polysaccharides block the upregulation of pro-apoptotic p53, Bax, and Bad while blocking downregulating anti-apoptotic Bcl-2 2. In vivo, aloe polysaccharides may act as a scavenger for oxygen free radicals including DPPH, alkyl radicals, superoxides, and singlet oxygen and hydroxyl radicals that may also be generated by superoxides 1,4. Hydrogen peroxide, which is a weak initiate lipid peroxidation, may also be effectively scavenged by aloe polysaccharides 4. In a Fenton reaction system, aloe polysaccharides demonstrated a concentration-dependent scavenging activity against hydroxyl radical that were generated during the reaction 4. Aloe polysaccharides may also compete with oxygen to react with nitric oxide (NO), thereby inhibiting the generation of nitrite and peroxynitrite anions that act as free radicals 4.
Findings from a study investigating the effects of aloe polysaccharides on doxorubicin-induced oxidative stress suggest that aloe polysaccharides mediate potent antioxidant actions in vivo 4. Doxorubicin, known to generate reactive oxygen species such as superoxide and hydroxy radicals, was administered to albino rats. This led to myocardial oxidative stress and cardiac injury accompanied by leakage of LDH and CPK from cardiac myocytes and to serum due to lipid peroxidation of cardiac membranes, reduced levels of antioxidant coenzyme GSH, and increased levels of SOD from a compensatory and combative mechanism of oxidative stress 4. Treatment with aloe polysaccharides resulted in a significant decrease in serum LDH and CPK levels, indicating that aloe polysaccharides are capable in stabilizing cardiac membranes from peroxidative damage. Restored levels of endogenous GSH and SOD in a dose-dependent manner were also observed with the treatment of aloe polysaccharides, suggesting that aloe polysaccharides exhibit potent antioxidant properties 4.
In a study of rats with open cutaneous back wounds, treatment with aloe polysaccharides decreased the levels of matrix metalloproteinase-3 (MMP-3) and induced tissue inhibitors of matrix metalloproteinase-2 (TIMP-2) during the early stage of wound repair, resulting in decreased collagen breakdown and increased preservation of collagen content in the injured area 6. A study proposes that acemannan, a common aloe polysaccharide, stimulates BMSC proliferation, ALPase activity, expression of VEGF, BMP-2, OPN, BSP, and mineralization leading to osteoblast differentiation and bone formation during socket healing 3.
Target Actions Organism AFree radicals chelatorHumans - Absorption
No pharmacokinetic data available.
- Volume of distribution
No pharmacokinetic data available.
- Protein binding
No pharmacokinetic data available.
- Metabolism
No pharmacokinetic data available.
- Route of elimination
No pharmacokinetic data available.
- Half-life
No pharmacokinetic data available.
- Clearance
No pharmacokinetic data available.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
The oral LD50 value of aloe polysaccharides in a mouse toxicity study was 6.1 g/kg 4. No cases of overdose reported.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Above Intimate Liquidsoap Liquid 0.01 mg/250g Topical Baston Industria de Aerossóis Ltda 2023-08-15 Not applicable US Aloe Vera Gel Gel 5 g/100g Topical Yuyao Jessie Commodity Co.,Ltd. 2014-05-08 Not applicable US Ato Stop Siseundeusi Lotion 63.52 g/100g Topical Gk Cosmetic Co., Ltd. 2016-11-18 Not applicable US Ato Stop Siseundeusi Cream 46.27 g/100g Topical Gk Cosmetic Co., Ltd. 2016-11-18 Not applicable US Baby Wipe Premium Cloth 1 g/1 Topical SHINWA INTERNATIONAL CORPORATION 2021-05-06 2021-05-11 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 75 Alcohol Hand Sanitizer Aloe vera leaf (1 mg/100mL) + Ethanol (75 mL/100mL) Liquid Extracorporeal Fujian Quanzhou Kete New Material Co., Ltd. 2020-04-26 Not applicable US Aloe Vera Sprayer Aloe vera leaf (2 g/100g) + Glycerin (4 g/100g) + Propylene glycol (2 g/100g) + Tocopherol (0.5 g/100g) Liquid Topical NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD 2015-02-20 Not applicable US AnubisMed Aloe vera leaf (0.15 g/50mL) + Imidurea (0.25 g/50mL) + Water (45.8293 mL/50mL) Liquid Topical ANUBIS COSMETICS SL 2022-10-26 2027-05-10 US ARILAC Soothing Mask Sheet Pack Aloe vera leaf (6.295 g/100mL) + Chamaecyparis obtusa wood oil (30.0 g/100mL) Patch Topical Menapay Inc. 2021-05-01 Not applicable US Atopim Aloe vera leaf (64 g/100g) + Glycerin (2.5 g/100g) Liquid Topical HI Technology 2019-05-11 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 75 Alcohol Hand Sanitizer Aloe vera leaf (1 mg/100mL) + Ethanol (75 mL/100mL) Liquid Extracorporeal Fujian Quanzhou Kete New Material Co., Ltd. 2020-04-26 Not applicable US Alcortin A Aloe vera leaf (10 mg/1g) + Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone acetate (20 mg/1g) Gel Topical Primus Pharmaceuticals 2010-01-01 Not applicable US Alcortin A Aloe vera leaf (10 mg/1g) + Diiodohydroxyquinoline (10 mg/1g) + Hydrocortisone acetate (20 mg/1g) Gel Topical Novum Pharma, Llc 2015-03-01 2021-08-31 US Aloquin Aloe vera leaf (10 mg/1g) + Diiodohydroxyquinoline (12.5 mg/1g) Gel Topical Primus Pharmaceuticals 2009-07-06 Not applicable US Aloquin Aloe vera leaf (10 mg/1g) + Diiodohydroxyquinoline (12.5 mg/1g) Gel Topical Novum Pharma, Llc 2015-03-01 2018-06-01 US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ZY81Z83H0X
- CAS number
- 8001-97-6
References
- General References
- Kang MC, Kim SY, Kim YT, Kim EA, Lee SH, Ko SC, Wijesinghe WA, Samarakoon KW, Kim YS, Cho JH, Jang HS, Jeon YJ: In vitro and in vivo antioxidant activities of polysaccharide purified from aloe vera (Aloe barbadensis) gel. Carbohydr Polym. 2014 Jan;99:365-71. doi: 10.1016/j.carbpol.2013.07.091. Epub 2013 Aug 31. [Article]
- Wang ZW, Zhou JM, Huang ZS, Yang AP, Liu ZC, Xia YF, Zeng YX, Zhu XF: Aloe polysaccharides mediated radioprotective effect through the inhibition of apoptosis. J Radiat Res. 2004 Sep;45(3):447-54. [Article]
- Boonyagul S, Banlunara W, Sangvanich P, Thunyakitpisal P: Effect of acemannan, an extracted polysaccharide from Aloe vera, on BMSCs proliferation, differentiation, extracellular matrix synthesis, mineralization, and bone formation in a tooth extraction model. Odontology. 2014 Jul;102(2):310-7. doi: 10.1007/s10266-012-0101-2. Epub 2013 Jan 12. [Article]
- Kaithwas G, Singh P, Bhatia D: Evaluation of in vitro and in vivo antioxidant potential of polysaccharides from Aloe vera (Aloe barbadensis Miller) gel. Drug Chem Toxicol. 2014 Apr;37(2):135-43. doi: 10.3109/01480545.2013.834350. Epub 2014 Feb 13. [Article]
- Surjushe A, Vasani R, Saple DG: Aloe vera: a short review. Indian J Dermatol. 2008;53(4):163-6. doi: 10.4103/0019-5154.44785. [Article]
- Tabandeh MR, Oryan A, Mohammadalipour A: Polysaccharides of Aloe vera induce MMP-3 and TIMP-2 gene expression during the skin wound repair of rat. Int J Biol Macromol. 2014 Apr;65:424-30. doi: 10.1016/j.ijbiomac.2014.01.055. Epub 2014 Jan 31. [Article]
- External Links
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Prevention Ulceration of the mouth 1 4 Completed Treatment Chronic Periodontitis (Disorder) / Diabetes Mellitus 1 4 Completed Treatment Periodontal inflammation / Periodontitis 1 4 Completed Treatment Periodontitis Chronic Generalized Severe 1 3 Unknown Status Treatment Bleeding / Infection / Postoperative Complications 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Extracorporeal Liquid Topical 0.01 mg/250g Gel Topical 5 g/100g Solution Oral Solution Oral 99.5 g/100mL Gel Topical Patch Topical Cream Topical 46.27 g/100g Lotion Topical 63.52 g/100g Cloth Topical 1 g/1 Swab Topical Patch Topical 10.0 g/20g Capsule Oral 250 mg / cap Tincture Respiratory (inhalation); Topical Liquid Nasal; Respiratory (inhalation) Liquid Respiratory (inhalation) Capsule, gelatin coated Oral Mouthwash Dental 20 g/100mL Capsule Oral Soap Topical 5 g/100g Cloth Topical Oil Vaginal 4.74 g/237mL Cream Topical Liquid Topical Tablet Oral Stick Topical Liquid Topical 100 g/100mL Powder Topical Tablet, film coated Oral 12.5 mg Stick Topical 2.62 g/35g Patch Topical 29 g/1001 Soap Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Liquid
- Experimental Properties
- Not Available
Targets
References
- Kaithwas G, Singh P, Bhatia D: Evaluation of in vitro and in vivo antioxidant potential of polysaccharides from Aloe vera (Aloe barbadensis Miller) gel. Drug Chem Toxicol. 2014 Apr;37(2):135-43. doi: 10.3109/01480545.2013.834350. Epub 2014 Feb 13. [Article]
Drug created at September 08, 2017 20:22 / Updated at August 06, 2021 21:26